Crypto News

Jun 08, 2026

Tango Therapeutics (TNGX) Stock Soars 45% Following Breakthrough Pancreatic Cancer Data

Stocks

TNGX stock surged 45% after clinical data revealed a 92% response rate in pancreatic cancer patients. Phase 3 trials expected to begin in 2026.

The post Tango Therapeutics (TNGX) Stock Soars 45% Following Breakthrough Pancreatic Cancer Data appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$BHYP$BMNR1D Bull Market Support Band200-day moving average200-week moving average200DMA200WMA21 Analytics24/7 trading30-Day MVRV314(b)401(K) crypto@wangtuai888AAPLABC Corrective PatternADAADA ProposalADA newsADA priceADAUSDT

Latest News